NCT00000427View on ClinicalTrials.gov

Effects of Parathyroid Hormone in Men With Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Osteoporosis
Interventions
DRUG

Parathyroid hormone

DRUG

Alendronate

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00000427 - Effects of Parathyroid Hormone in Men With Osteoporosis | Biotech Hunter | Biotech Hunter